Amgen rating suspended at JPMorgan as it acts as adviser to Horizon Therapeutics

Amgen, Inc.

hapabapa/iStock Editorial via Getty Images

  • Amgen's (NASDAQ:AMGN) rating was suspended at JPMorgan as the bank is acting as a financial adviser to Horizon Therapeutics (NASDAQ:HZNP) in a potential sale.
  • JPMorgan suspended its rating on Thursday after Horizon Therapeutics confirmed on

Recommended For You

Comments (5)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.